Fapon Executive and Leadership Team

Brijesh Singh, the International Bd Unit Director & Chief Executive Officer (India) at Fapon, directs all strategic expansion efforts across the South Asian market. Singh architects high-level partnerships with healthcare providers to integrate diagnostic reagent solutions into clinical workflows. By overseeing regional operations, the International Bd Unit Director & Chief Executive Officer (India) ensures that Fapon maintains a competitive edge in the rapidly evolving in vitro diagnostics sector. This leadership role involves managing complex regulatory landscapes and driving revenue growth through localized product adoption. Brijesh Singh also coordinates with global headquarters to align regional sales targets with the broader corporate mission of improving diagnostic accessibility. Through rigorous market analysis and operational oversight, the International Bd Unit Director & Chief Executive Officer (India) secures long-term sustainability for the company within the Indian healthcare ecosystem, ultimately fostering stronger diagnostic capabilities for diverse patient populations.

Paul Lundquist, the Chief Technology Officer, Sequencing at Fapon, leads the research and development initiatives focused on advanced sequencing platforms. Lundquist architects the technical roadmap for next-generation diagnostic tools, ensuring that the company remains at the forefront of molecular biology innovation. Overseeing the engineering teams, the Chief Technology Officer, Sequencing drives the integration of high-throughput sequencing technologies into the existing portfolio of diagnostic reagents. This leadership role requires constant collaboration with the product development department to refine instrument performance and data accuracy. Paul Lundquist also manages the intellectual property strategy related to sequencing breakthroughs, protecting the technological assets of the organization. By optimizing internal research processes, the Chief Technology Officer, Sequencing accelerates the time-to-market for new diagnostic solutions. Through this technical focus, the Chief Technology Officer, Sequencing supports the overarching mission of providing precise, reliable, and scalable diagnostic technologies to global healthcare partners.

Hongxia Zheng, the Chief Medical Officer at Fapon, oversees the clinical validation and medical affairs strategy for all diagnostic products. Zheng architects the protocols for clinical trials, ensuring that every reagent and instrument platform meets rigorous international safety and efficacy standards. By managing relationships with medical institutions and regulatory bodies, the Chief Medical Officer ensures that the company maintains compliance while advancing clinical research. This leadership role involves interpreting complex medical data to guide product development and marketing strategies. Hongxia Zheng also provides critical medical insights to the executive team, shaping the long-term vision for diagnostic innovation. Through the oversight of clinical evidence generation, the Chief Medical Officer validates the performance of antigen detection kits and other diagnostic solutions. Ultimately, the Chief Medical Officer strengthens the reputation of the company by ensuring that all medical outputs directly contribute to improved patient outcomes and diagnostic precision.

Yi Ke, the 产线销售负责人 at Fapon, directs the commercial strategy and sales execution for the company's diverse production lines. Ke architects the distribution networks that deliver high-quality diagnostic reagents to healthcare facilities across various regions. By overseeing the sales force, the 产线销售负责人 ensures that market demand for antigen detection kits and instrument platforms receives consistent fulfillment. This leadership role involves analyzing market trends to adjust pricing and inventory strategies, thereby maximizing operational efficiency. Yi Ke also collaborates with the product management team to identify new opportunities for market penetration and customer acquisition. Through the management of key accounts, the 产线销售负责人 drives revenue growth and strengthens the company's market position. By maintaining a focus on customer satisfaction and service reliability, Yi Ke ensures that the production line sales operations support the broader corporate goal of providing essential diagnostic solutions to the global healthcare sector.